Abstract
Background and Aims: Direct oral anticoagulants (DOACs) are now used safely in nonvalvular atrial fibrillation (AF), while no sufficient data about their usage for left atrial/left atrial appendage (LAA) thrombi instead of the commonly used vitamin K antagonists (VKAs).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
